CANNABINOID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF
申请人:CALIFORNIA AMBER INC.
公开号:US20210068444A1
公开(公告)日:2021-03-11
Provided herein are compositions comprising cannabinoids, terpenoids, and other flavonoids. Also provided herein are methods for producing compositions comprising cannabinoids, terpenoids, and other flavonoids at industrial scale. In certain embodiments, the compositions provided herein possess desirable organoleptic properties and therapeutic effects when ingested or topically applied. In certain embodiments, the compositions of the present disclosure have are useful in inhalable, ingestible, or topical products to relieve and treat various acute or chronic illnesses.
[EN] CANNABIN OID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF<br/>[FR] COMPOSITIONS DE CANNABINOÏDES À PROPRIÉTÉS ORGANOLEPTIQUES ET THÉRAPEUTIQUES AMÉLIORÉES, LEUR PROCÉDÉ DE PRODUCTION ET LEUR UTILISATION
申请人:CALIFORNIA AMBER INC
公开号:WO2021050786A1
公开(公告)日:2021-03-18
Provided herein are compositions comprising cannabinoids, terpenoids, and other flavonoids. Also provided herein are methods for producing compositions comprising cannabinoids, terpenoids, and other flavonoids at industrial scale. In certain embodiments, the compositions provided herein possess desirable organoleptic properties and therapeutic effects when ingested or topically applied. In certain embodiments, the compositions of the present disclosure have are useful in inhalable, ingestible, or topical products to relieve and treat various acute or chronic illnesses.
Propanolysis of Esters Using Chlorotrimethylsilane
Abstract A variety of methyl esters are converted into the corresponding propyl esters upon treatment with l-propanol and chlorotrimethylsilane. Among them acyclic aliphatic esters have the best conversion rate.